(Q44146892)

30 November 2017

title

Antibodies to Plasmodium vivax transmission-blocking vaccine candidate antigens Pvs25 and Pvs28 do not show synergism (English)

1 reference

30 November 2017

0 references

1 reference

3

1 reference

30 November 2017

2

Collins WE

1 reference

30 November 2017

Hisaeda H

1

1 reference

30 November 2017

Stowers AW

series ordinal

4

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2001

1 reference

30 November 2017

1 reference

30 November 2017

volume

20

1 reference

30 November 2017

issue

5-6

1 reference

30 November 2017

page(s)

763-770

1 reference

Cloning and expression of the gene coding for the transmission blocking target antigen Pfs48/45 of Plasmodium falciparum

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

A central role for P48/45 in malaria parasite male gamete fertility

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Recombinant Pfs25 protein of plasmodium falciparum elicits malaria transmission-blocking immunity in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

A vaccine candidate from the sexual stage of human malaria that contains EGF-like domains

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Biosynthesis of two stage-specific membrane proteins during transformation of Plasmodium gallinaceum zygotes into ookinetes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Pgs28 belongs to a family of epidermal growth factor-like antigens that are targets of malaria transmission-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Antibodies to malaria vaccine candidates Pvs25 and Pvs28 completely block the ability of Plasmodium vivax to infect mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

A novel malaria protein, Pfs28, and Pfs25 are genetically linked and synergistic as falciparum malaria transmission-blocking vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Sequence polymorphism in two novel Plasmodium vivax ookinete surface proteins, Pvs25 and Pvs28, that are malaria transmission-blocking vaccine candidates.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Saccharomyces cerevisiae-secreted fusion proteins Pfs25 and Pfs28 elicit potent Plasmodium falciparum transmission-blocking antibodies in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Characterisation and expression of pbs25, a sexual and sporogonic stage specific protein of Plasmodium berghei.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

A region of Plasmodium falciparum antigen Pfs25 that is the target of highly potent transmission-blocking antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

Advances in vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900402-9

7 January 2021

10.1016/S0264-410X(01)00402-9

Identifiers

DOI

1 reference

30 November 2017

1 reference